All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...857Next →

hiv & aids news selected from other sources

  • Experiences of stigma
    Greece's LGBTI people defiant in face of homophobic arson attack
    Gay Star News | 22 hours ago

    Just hours after arsonists targeted a major HIV testing center, the center resumed providing tests for people in Athens.

  • PrEP programmes and uptake
    PrEP Use Among Gay and Bi Men Hits a New High
    Poz | 22 hours ago

    A third of at-risk gay and bi men are now using Truvada for HIV prevention, the CDC says.

  • Tuberculosis and HIV
    The Lancet: Experts set out targets to eliminate tuberculosis within a generation
    Eurekalert Inf Dis | 23 hours ago

    A world free of tuberculosis (TB) is possible by 2045 if increased political will and financial resources are directed towards priority areas including providing evidence-based interventions to everyone, especially to high risk groups, and increasing research to develop new ways to diagnose, treat, and prevent TB. Funding this response will require substantial investments, and accountability mechanisms will be necessary to ensure that promises are kept and targets are reached.

  • Confidentiality, consent and medical ethics
    “I have HIV, now what?” Tracking cookies found on NHS advice pages
    New Statesman | 20 March 2019

    Invasive tracking technology been covertly installed on more than a dozen NHS landing pages about sensitive medical conditions, new research has revealed.

  • Sexually transmitted infections treatment
    Pipeline for Gonorrhea, Chlamydia, and Syphilis
    TAG | 20 March 2019

    A new report on the sexually transmitted infection (STI) treatment and prevention research “pipeline” points to serious gaps in the development of new tools to address a growing epidemic in the U.S. The report, released today by Treatment Action Group (TAG), provides an assessment of the current research pipeline and calls for a major new investment in STI research.

  • PrEP science
    On-Demand PrEP With TDF/FTC Not Associated With Clinically Relevant Decline in Kidney Function
    Contagion Live | 20 March 2019

    On-demand pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) is not associated with a significant relevant in kidney function, especially among young people with low pill use and high baseline estimated glomerular filtration rate, investigators in France found.

  • New and experimental HIV treatments
    Trogarzo’s Effects on Hard-to-Treat HIV Are Stable Over Two Years
    Poz | 20 March 2019

    Researchers followed a small group of people with highly drug-resistant virus taking Trogarzo (ibalizumab-uiyk) plus an optimized background regimen.

  • Confidentiality, consent and medical ethics
    CDC Explains and Defends Molecular Surveillance System
    The Body | 19 March 2019

    The Centers for Disease Control and Prevention (CDC) used part of a plenary session at the March 4-7 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle to explain and defend the agency's molecular surveillance program. The presentation was given by Alexandra Oster, M.D., a medical epidemiologist who has worked on this research for the CDC for over ten years. Oster began her presentation by arguing that cluster detection and response can help bring the nation closer to ending the HIV epidemic by allowing us to identify when HIV is being transmitted rapidly, and when public health can step in to stop transmission.

  • Achieving the 90-90-90 target
    US: 80% of new HIV cases transmitted by undiagnosed or untreated people
    Healio | 19 March 2019

    In 2016, more than 80% of new HIV infections in the United States were transmitted by individuals who either did not know they were infected with HIV or had been diagnosed but were not receiving care, according to data released on the first day of the National HIV Prevention Conference in Atlanta.

  • Drug policy and policing
    New UN guidelines to mainstream human rights in the global drugs debate
    The Conversation | 19 March 2019

    In early March, the Chief Executives Board of the United Nations, representing 31 UN agencies – including the World Health Organisation, UNICEF, the High Commissioner for Human Rights and the UN Office on Drugs and Crime – adopted a common position on drug policy. Among the actions agreed is was a commitment to “support the development and implementation of policies that put people, health and human rights at the centre … and to promote a rebalancing of drug policies and interventions towards public health approaches”.

← First12345...15Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2019).

aidsmapLIVE

Watch our AIDS 2018 aidsmapLIVE panel discussion on YouTube.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.